Official Title
Oxycodone Extended-release in the Treatment of Perioperative Pain in Patients Undergoing Orthopaedic Surgery
Phase
Phase 4Lead Sponsor
Hospital Central Dr. Luis OrtegaStudy Type
InterventionalStatus
Completed No Results PostedIndication/Condition
SurgeryIntervention/Treatment
ketoprofen urea oxycodone metamizole morphine ...Study Participants
40Inadequate control of acute postoperative pain (DAPO) brings deleterious consequences for the patient, including significant cardiovascular and respiratory complications. Apart from the human suffering that is undeniable pain. Schemes oral analgesia with opioids for the treatment of DAPO, have shown to be as or more effective than intravenous or epidural regimes, and less expensive. Comparing the effectiveness of 10 to 20 mgs of oxycodone sustained release for 12 hours before surgery, into two groups of 20 patients (O-10, O-20) undergoing orthopedic surgery, in a scheme involving multimodal ketoprofen, dipyrone metoclopramide and dexamethasone. Values were recorded visual analog scale (VAS)for pain at rest and effort, requirement for rescue intravenous morphine and incidence of side effects to the entry and exit of the PACU (T0, TE) and at 6 and 18 hours postoperatively (T6, T18),and patient satisfaction.
10 o 20 mgrs of extended-release oxycodone ,started 12 hours before orthopaedic surgery
Extended-release oxycodone 10 mgrs , started 12 hours before orthopaedic surgery
Extended-release oxycodone 20 mgr , started 12 hours before orthopaedic surgery
Inclusion Criteria: ASA I and II patients between 18 and 60 years old, both sexes, undergoing elective orthopedic surgery. Exclusion Criteria: Use of psychotropic medication or illicit drug use Pregnancy Liver disease Opioid use History of postoperative nausea and vomiting Ileus Allergy or intolerance to any of the study drugs Physical or mental inability to use the pain scale, or any surgical complications.